Skip to content

ENTA - ENANTA PHARMACEUTICALS INC - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchE

Enanta Pharmaceuticals Inc

ENTA · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

E

ENTAEnanta Pharmaceuticals Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $17.15
52-wk low: $7.05
Prev close: $13.64
Mkt cap: $393.5M
Fwd P/E: 44.0x
Beta: 0.93

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$121.1M

FC
Farallon Capital
Q2 2026 13F
$35.3M
position
MI
Millennium
Israel Englander · Q2 2026 13F

Earnings

Reported Aug 10, 2026

Earnings came in 81.1% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -96.9%
Forward P/E: 44.05
Market cap: $393M

Valuation

P/S6.03
P/B3.83

Quality

Operating margin-120.0%

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: ENTA
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $393.48M
Beta: 0.93

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/S

6.0x

P/B

3.8x

Profit margin

-96.9%

Op margin

-120.0%

ROE

-70.1%

$9.4M

position

JS

Jim Simons

Q2 2026 13F

$8.1M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for ENTA

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.67-81.1%

-$0.37 expected

Next report

What the street expects next

EPS expected

-$0.87

-$0.95 to -$0.70

Revenue expected

$16.2M

3 analysts

Last 30 days

2up1down

Analysts raising estimates

Estimate drift

0.24

Change in 30 days

ROE

-70.1%

ROA-12.3%

Growth

Beta0.93